Cell and Immunology Core

$188,821P30FY2016DANIH

Temple Univ Of The Commonwealth, Philadelphia PA

Investigators

Linked publications & trials

Paper 39702361 Paper 39620471 Paper 39518941 Paper 39517684 Paper 39433903 Paper 39300273 Paper 39053627 Paper 38854027 Paper 38534474 Paper 38514040 Paper 38409113 Paper 38293836 Paper 38199516 Paper 38116176 Paper 38076811 Paper 38036039 Paper 37625214 Paper 37573960 Paper 37508844 Paper 37392779 Paper 37376759 Paper 36871847 Paper 36815027 Paper 36534642 Paper 36521236 Paper 36408401 Paper 36238569 Paper 36174884 Paper 36139385 Paper 36093282 Paper 36017612 Paper 35905805 Paper 35843139 Paper 35792570 Paper 35779192 Paper 35652052 Paper 35529434 Paper 35514978 Paper 35320877 Paper 35216375 Paper 35163373 Paper 35051699 Paper 34979130 Paper 34871976 Paper 34736959 Paper 34576988 Paper 34531761 Paper 34500853 Paper 34435263 Paper 34290298 Paper 34244232 Paper 34146575 Paper 34085120 Paper 33940234 Paper 33834276 Paper 33826336 Paper 33758061 Paper 33754230 Paper 33689166 Paper 33648543 Paper 33631465 Paper 33593913 Paper 33590767 Paper 33580386 Paper 33465606 Paper 33404775 Paper 33380174 Paper 33291057 Paper 33231727 Paper 33042154 Paper 32976891 Paper 32897695 Paper 32814790 Paper 32585256 Paper 32517185 Paper 32454064 Paper 32243899 Paper 32145665 Paper 32076421 Paper 31908004 Paper 31867624 Paper 31783102 Paper 31756109 Paper 31734036 Paper 31682867 Paper 31568781 Paper 31557508 Paper 31420527 Paper 31361029 Paper 31347447 Paper 31313616 Paper 31302200 Paper 31279825 Paper 31275220 Paper 31236436 Paper 31218677 Paper 31029877 Paper 30980094 Paper 30951749 Paper 30905008

Abstract

The Cell and Immunology Core will to continue to offer assays to extend the work of laboratories at Temple University and of outside collaborators who want to add immune or histological/pathological end-points to their studies. Dr. Eisenstein will supervise the work to be carried out in Aims 1, 2, and 4. A major addition to the Core in this renewal is Dr. Yuri Persidsky. Trained as a pathologist, he will supervise new services offered by the Cell and Immunology Core as related to analysis of tissue as described in Aim 3. In addition, he will bring his expertise in HIV-1 infection of relevant human cells and the blood-brain barrier (BBB) to the Core, as well as projects using the HIV-1-infected humanized NOD.Cg-Prkdcscid ll2rgtm1Wjl /SzJ (NSG mice or huNSG) mouse model that recapitulates key features of infection in humans.

View original record on NIH RePORTER →